|
Market Closed -
Canadian Securities Exchange
07:01:18 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -83.33% |
| Market Cap | 11.94L 9L 7L 7L 6L 8.3Cr 12.1L 82.11L 32.02L 4.17Cr 32.56L 31.85L 14Cr | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5L 3L 3L 3L 3L 3.27Cr 5L 32.35L 12.62L 1.64Cr 12.83L 12.55L 5.43Cr | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -33.33% | ||
| 6 months | -50.00% | ||
| Current year | -83.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0 | 0.05 | |
| 1 year | 0 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 0.75 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 46,67,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 2,00,000 | 0.1675% | ||
| 21/03/25 | Buy | Chief Executive Officer | 1,00,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -77.78% | 9L | ||
| +0.88% | +6.38% | +76.40% | +126.75% | 1,11900Cr | ||
| +1.07% | +3.80% | +50.73% | +62.78% | 65TCr | ||
| +1.20% | +6.21% | +25.81% | +78.74% | 47TCr | ||
| +1.02% | +5.77% | +43.63% | +48.43% | 37TCr | ||
| +0.85% | +4.07% | +24.97% | +40.58% | 30TCr | ||
| +1.26% | +6.81% | +2.27% | +14.41% | 26TCr | ||
| +1.88% | +5.81% | +49.57% | +70.53% | 24TCr | ||
| +1.59% | +2.09% | -17.33% | -52.62% | 21TCr | ||
| +1.87% | +5.61% | +27.32% | +91.38% | 18TCr | ||
| Average | +1.16% | +4.48% | +28.34% | +40.32% | 38TCr | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.26% | +72.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 43.42L 31.53L 27.01L 25.27L 23.14L 30Cr 43.99L 2.99Cr 1.16Cr 15Cr 1.18Cr 1.16Cr 50Cr | 33.61L 24.41L 20.91L 19.56L 17.91L 23Cr 34.05L 2.31Cr 90.13L 12Cr 91.65L 89.65L 39Cr |
| Net income | -1.65Cr -1.2Cr -1.03Cr -96.06L -87.93L -114.67Cr -1.67Cr -11Cr -4.43Cr -58Cr -4.5Cr -4.4Cr -190.53Cr | -89.1L -64.71L -55.43L -51.87L -47.48L -62Cr -90.28L -6.13Cr -2.39Cr -31Cr -2.43Cr -2.38Cr -102.87Cr |
| Net Debt | -6L -5L -4L -4L -3L -4.35Cr -6L -43.03L -16.78L -2.18Cr -17.06L -16.69L -7.22Cr | -7L -5L -5L -4L -4L -5.03Cr -7L -49.76L -19.4L -2.53Cr -19.73L -19.3L -8.35Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















